MRI-guided Neurosurgical Ablation Market is Poised to Grow at a CAGR of 8% to Reach US$ 1.29 Billion by 2033

The MRI-Guided Neurosurgical Ablation market (MRI タイド下脳脳最作アブレーズ市場) is valued at around USD 598.99 in 2020, according to a recent global neurosurgery study. Surgical ablation systems are projected to grow at a CAGR of 8 percent. By 2033, the market is expected to reach approximately US$1.29 billion.

One innovative and minimally invasive neurosurgical technique used to treat brain tumors is MRI-guided laser ablation. This procedure uses laser technology to precisely target and remove the tumor. Compared to traditional open surgery called craniotomy, MRI-guided ablation has several advantages, including reduced postoperative pain and faster recovery time.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8318

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

AngioDynamics Inc
Boston Scientific Corporation
Insightec Ltd
Medtronic PLC
Monteris Medical Inc
MRI Intervention In

𝐓𝐡𝐞 𝐄𝐩𝐢𝐝𝐞𝐦𝐢𝐜 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬

Neurological disorders include a variety of diseases that affect the brain, spinal cord and nervous system. These disorders can vary in severity, but many are debilitating and can significantly reduce a person's quality of life. Some of the most common neurological disorders are:

Brain Tumors: Brain tumors can be benign or malignant and require surgical intervention. Accurate and precise care is essential to preserve brain function and improve patient outcomes.
Epilepsy: Epilepsy is a chronic neurological disease characterized by recurrent seizures. For some patients, medications are ineffective, necessitating surgical options such as ablation.
Parkinson's disease: Parkinson's disease is a progressive neurological disease that affects movement. Advanced treatments, including ablation procedures, can relieve symptoms and improve patients' daily lives.
Essential tremor: Essential tremor is a neurological condition that causes involuntary shaking. MR-guided ablation has shown promise in reducing tremor when medications fail.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Several factors are contributing to the rapid growth of the MRI-guided neurosurgical ablation market:

Increased rate of diagnosis: Improved diagnostic tools and increased awareness of neurological diseases have led to earlier and more accurate diagnosis. This in turn increases the demand for effective treatment options such as MRI-guided ablation.
Advances in Technology: Continued innovations in MRI technology, such as real-time imaging and advanced software, have made MRI-guided ablation procedures more accessible and effective for neurosurgeons.
Aging population: The world's population is aging and neurological diseases often increase with age. This demographic change is expected to contribute to the continued growth of the market.
Patient demand: Patients are increasingly looking for minimally invasive and precise treatments that offer faster recovery times and better results. MRI-guided neurosurgical ablation meets these requirements.
Investments and Research: Pharmaceutical companies and medical device manufacturers invest heavily in research and development to improve the capabilities of MRI-guided ablation systems.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

To gain a competitive advantage, companies increasingly focus on research and development to produce technologically advanced products. The main goal is to improve product quality standards.

A notable example of commitment to innovation is MRI Interventions, Inc., a major player in the field of neurosurgery. In January 2019, they received US FDA approval for their ClearPoint PURSUIT Neuro Aspiration System. This system, developed in collaboration with the Mayo Clinic, is designed for the precise suction of abscesses, cerebrospinal fluid, thrombi and cystic tumors.

Similarly, in April 2018, Medtronic launched Visualase, an MRI-guided laser ablation system, on the European market . This minimally invasive laser treatment is tailored to treat brain-related problems, providing precise targeting and treatment to specific unwanted tissue areas.

In addition, companies are actively pursuing strategic moves such as mergers, collaborations and acquisitions to expand their product offerings. , improve production capacity, optimize supply chain management and gain a wider range of competitive advantages.

An example of this strategic approach is Insightec, which secured a major investment of USD 150 million in March 2020. This funding is earmarked. to develop an incision-less surgical device for people with tremor-like Parkinson's disease unresponsive to traditional medications.

In another development, in February 2019, Medtronic introduced Accuriani, a state-of-the-art radiofrequency ablation technology. This innovative system features state-of-the-art hardware, advanced temperature control software and a quad-core processor, all carefully designed to improve the efficiency of standard, pulsed and advanced procedures.

𝐌𝐑𝐈-𝐠𝐮𝐢𝐝𝐞𝐝 𝐍𝐞𝐮𝐫𝐨𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬

By Product :
RF Ablation Systems
Laser Ablation Systems
Focused Ultrasound Systems
Accessories

By End User :
Hospitals
Ambulatory Surgical Centers
Clinics
Research Laboratories

By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/mri-guided-neurosurgical-ablation-market

The rising incidence of neurological disorders is a significant driver behind the expanding MRI-guided neurosurgical ablation market. As the global healthcare community continues to grapple with the challenges posed by these complex conditions, innovative technologies like MRI-guided ablation offer hope for improved patient outcomes and a better quality of life. With ongoing research and technological advancements, the future of neurosurgery appears promising, promising new opportunities for patients and medical professionals alike.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.